ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 000406

Potential neurotoxic "agents provocateurs" in Parkinson's disease

Identifieur interne : 000406 ( PascalFrancis/Curation ); précédent : 000405; suivant : 000407

Potential neurotoxic "agents provocateurs" in Parkinson's disease

Auteurs : Michael A. Collins [États-Unis] ; Edward J. Neafsey [États-Unis]

Source :

Neurotoxicology and teratology [ 0892-0362 ] ; 2002.

RBID : Pascal:03-0017996

Descripteurs français

Pascal (Inist)
- Voie dopaminergique, Etiologie, Amine, Parkinson maladie, Pesticide, Carboline dérivé, Isoquinoléine dérivé, Homme, Animal, Toxicité.
Wicri :
- topic : Pesticide, Homme.

English descriptors

KwdEn :
- Amine, Animal, Carboline derivatives, Dopaminergic pathway, Etiology, Human, Isoquinoline derivatives, Parkinson disease, Pesticides, Toxicity.

Abstract

Idiopathic Parkinson's disease (PD), one of the most common neurodegenerative disorders associated with aging, is characterized neurochemically by abnormal and profound loss of nigrostriatal dopamine (DA) neurons. A prominent current view is that the excessive degeneration of the dopaminergic system is the outcome of extended insults by environmental neurotoxins or endogenous neurotoxic factors in genetically vulnerable or susceptible individuals. Recent insights into the identities and mechanisms of potential neurotoxic species, which span pesticides, environmental contaminants including heterocyclic amines with β-carboline (βC) and isoquinoline (IQ) structures, endogenous DA metabolites or intermediates, neuromelanin, metals, and infectious agents, are presented.

A01	`01`	`1`		`@0 0892-0362`
A02	`01`			`@0 NETEEC`
A03		`1`		`@0 Neurotoxicol. teratol.`
A05				`@2 24`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 Potential neurotoxic "agents provocateurs" in Parkinson's disease`
A09	`01`	`1`	`ENG`	`@1 Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu`
A11	`01`	`1`		`@1 COLLINS (Michael A.)`
A11	`02`	`1`		`@1 NEAFSEY (Edward J.)`
A12	`01`	`1`		`@1 NAOI (Makoto) @9 ed.`
A12	`02`	`1`		`@1 PARVEZ (Hasan) @9 ed.`
A12	`03`	`1`		`@1 MARUYAMA (Wakako) @9 ed.`
A12	`04`	`1`		`@1 COLLINS (Michel A.) @9 ed.`
A12	`05`	`1`		`@1 YOUDIM (Moussa B. H.) @9 ed.`
A14	`01`			`@1 Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue @2 Maywood, IL 60153 @3 USA @Z 1 aut. @Z 2 aut.`
A15	`01`			`@1 Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park @2 Mitake, Gifu 505-0116 @3 JPN @Z 1 aut.`
A15	`02`			`@1 Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS @2 91190 Gif sur Yvette @3 FRA @Z 2 aut.`
A15	`03`			`@1 Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences @2 Obu, Aichi 474-8622 @3 JPN @Z 3 aut.`
A15	`04`			`@1 Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine @2 Maywood, IL 60153 @3 USA @Z 4 aut.`
A15	`05`			`@1 Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion @2 Haifa 31096 @3 ISR @Z 5 aut.`
A20				`@1 571-577`
A21				`@1 2002`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 18910 @5 354000109244300020`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 97 ref.`
A47	`01`	`1`		`@0 03-0017996`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Neurotoxicology and teratology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Idiopathic Parkinson's disease (PD), one of the most common neurodegenerative disorders associated with aging, is characterized neurochemically by abnormal and profound loss of nigrostriatal dopamine (DA) neurons. A prominent current view is that the excessive degeneration of the dopaminergic system is the outcome of extended insults by environmental neurotoxins or endogenous neurotoxic factors in genetically vulnerable or susceptible individuals. Recent insights into the identities and mechanisms of potential neurotoxic species, which span pesticides, environmental contaminants including heterocyclic amines with β-carboline (βC) and isoquinoline (IQ) structures, endogenous DA metabolites or intermediates, neuromelanin, metals, and infectious agents, are presented.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Voie dopaminergique @5 01`
C03	`01`	`X`	`ENG`	`@0 Dopaminergic pathway @5 01`
C03	`01`	`X`	`SPA`	`@0 Vía dopaminérgica @5 01`
C03	`02`	`X`	`FRE`	`@0 Etiologie @5 04`
C03	`02`	`X`	`ENG`	`@0 Etiology @5 04`
C03	`02`	`X`	`SPA`	`@0 Etiología @5 04`
C03	`03`	`X`	`FRE`	`@0 Amine @5 07`
C03	`03`	`X`	`ENG`	`@0 Amine @5 07`
C03	`03`	`X`	`SPA`	`@0 Amina @5 07`
C03	`04`	`X`	`FRE`	`@0 Parkinson maladie @5 10`
C03	`04`	`X`	`ENG`	`@0 Parkinson disease @5 10`
C03	`04`	`X`	`SPA`	`@0 Parkinson enfermedad @5 10`
C03	`05`	`X`	`FRE`	`@0 Pesticide @5 11`
C03	`05`	`X`	`ENG`	`@0 Pesticides @5 11`
C03	`05`	`X`	`SPA`	`@0 Plaguicida @5 11`
C03	`06`	`X`	`FRE`	`@0 Carboline dérivé @2 FR @5 12`
C03	`06`	`X`	`ENG`	`@0 Carboline derivatives @2 FR @5 12`
C03	`07`	`X`	`FRE`	`@0 Isoquinoléine dérivé @2 FR @5 13`
C03	`07`	`X`	`ENG`	`@0 Isoquinoline derivatives @2 FR @5 13`
C03	`07`	`X`	`SPA`	`@0 Isoquinoleína @2 FR @5 13`
C03	`08`	`X`	`FRE`	`@0 Homme @5 14`
C03	`08`	`X`	`ENG`	`@0 Human @5 14`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 14`
C03	`09`	`X`	`FRE`	`@0 Animal @5 15`
C03	`09`	`X`	`ENG`	`@0 Animal @5 15`
C03	`09`	`X`	`SPA`	`@0 Animal @5 15`
C03	`10`	`X`	`FRE`	`@0 Toxicité @5 16`
C03	`10`	`X`	`ENG`	`@0 Toxicity @5 16`
C03	`10`	`X`	`SPA`	`@0 Toxicidad @5 16`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 61`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 61`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 61`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 62`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 62`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 62`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 63`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 63`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 63`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 64`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 64`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 64`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 65`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 65`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 65`
N21				`@1 006`
N82				`@1 PSI`

A30	`01`	`1`	`ENG`	`@1 International Catecholamine Symposium @2 9 @3 Kyoto JPN @4 2001-03-31`
A30	`02`	`1`	`ENG`	`@1 International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease @2 5 @3 Kyoto JPN @4 2001-03-31`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001028

Links to Exploration step

Pascal:03-0017996

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Potential neurotoxic "agents provocateurs" in Parkinson's disease</title>
<author><name sortKey="Collins, Michael A" sort="Collins, Michael A" uniqKey="Collins M" first="Michael A." last="Collins">Michael A. Collins</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Neafsey, Edward J" sort="Neafsey, Edward J" uniqKey="Neafsey E" first="Edward J." last="Neafsey">Edward J. Neafsey</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0017996</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0017996 INIST</idno>
<idno type="RBID">Pascal:03-0017996</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001028</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000406</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Potential neurotoxic "agents provocateurs" in Parkinson's disease</title>
<author><name sortKey="Collins, Michael A" sort="Collins, Michael A" uniqKey="Collins M" first="Michael A." last="Collins">Michael A. Collins</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Neafsey, Edward J" sort="Neafsey, Edward J" uniqKey="Neafsey E" first="Edward J." last="Neafsey">Edward J. Neafsey</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amine</term>
<term>Animal</term>
<term>Carboline derivatives</term>
<term>Dopaminergic pathway</term>
<term>Etiology</term>
<term>Human</term>
<term>Isoquinoline derivatives</term>
<term>Parkinson disease</term>
<term>Pesticides</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Voie dopaminergique</term>
<term>Etiologie</term>
<term>Amine</term>
<term>Parkinson maladie</term>
<term>Pesticide</term>
<term>Carboline dérivé</term>
<term>Isoquinoléine dérivé</term>
<term>Homme</term>
<term>Animal</term>
<term>Toxicité</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Pesticide</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Idiopathic Parkinson's disease (PD), one of the most common neurodegenerative disorders associated with aging, is characterized neurochemically by abnormal and profound loss of nigrostriatal dopamine (DA) neurons. A prominent current view is that the excessive degeneration of the dopaminergic system is the outcome of extended insults by environmental neurotoxins or endogenous neurotoxic factors in genetically vulnerable or susceptible individuals. Recent insights into the identities and mechanisms of potential neurotoxic species, which span pesticides, environmental contaminants including heterocyclic amines with β-carboline (βC) and isoquinoline (IQ) structures, endogenous DA metabolites or intermediates, neuromelanin, metals, and infectious agents, are presented.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0892-0362</s0>
</fA01>
<fA02 i1="01"><s0>NETEEC</s0>
</fA02>
<fA03 i2="1"><s0>Neurotoxicol. teratol.</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Potential neurotoxic "agents provocateurs" in Parkinson's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>COLLINS (Michael A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>NEAFSEY (Edward J.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>NAOI (Makoto)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>PARVEZ (Hasan)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>MARUYAMA (Wakako)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>COLLINS (Michel A.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1"><s1>YOUDIM (Moussa B. H.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Cell Biology, Neurobiology, and Anatomy, Division of Biochemistry, Loyola University School of Medicine, 2160 South First Avenue</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park</s1>
<s2>Mitake, Gifu 505-0116</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS</s1>
<s2>91190 Gif sur Yvette</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences</s1>
<s2>Obu, Aichi 474-8622</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="04"><s1>Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA15 i1="05"><s1>Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion</s1>
<s2>Haifa 31096</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</fA15>
<fA20><s1>571-577</s1>
</fA20>
<fA21><s1>2002</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18910</s2>
<s5>354000109244300020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>97 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0017996</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Neurotoxicology and teratology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Idiopathic Parkinson's disease (PD), one of the most common neurodegenerative disorders associated with aging, is characterized neurochemically by abnormal and profound loss of nigrostriatal dopamine (DA) neurons. A prominent current view is that the excessive degeneration of the dopaminergic system is the outcome of extended insults by environmental neurotoxins or endogenous neurotoxic factors in genetically vulnerable or susceptible individuals. Recent insights into the identities and mechanisms of potential neurotoxic species, which span pesticides, environmental contaminants including heterocyclic amines with β-carboline (βC) and isoquinoline (IQ) structures, endogenous DA metabolites or intermediates, neuromelanin, metals, and infectious agents, are presented.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Voie dopaminergique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dopaminergic pathway</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Vía dopaminérgica</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Etiologie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Etiology</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Etiología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Amine</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Amine</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Amina</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pesticide</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Pesticides</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Plaguicida</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Carboline dérivé</s0>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Carboline derivatives</s0>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Isoquinoléine dérivé</s0>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Isoquinoline derivatives</s0>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Isoquinoleína</s0>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Animal</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Animal</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Animal</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21><s1>006</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>International Catecholamine Symposium</s1>
<s2>9</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
<fA30 i1="02" i2="1" l="ENG"><s1>International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease</s1>
<s2>5</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
</pR>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000406 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000406 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0017996
   |texte=   Potential neurotoxic "agents provocateurs" in Parkinson's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Potential neurotoxic "agents provocateurs" in Parkinson's disease

Potential neurotoxic "agents provocateurs" in Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri